Lupus anticoagulant positivity in insulin dependent diabetic patients: An additional risk factor in the pathogenesis of diabetic retinopathy?

British Journal of Ophthalmology

Volumn 84, Issue 5, 2000, Pages 531-533

  Giusti, Cristiano ^a   Schiaffini, Riccardo ^b   Bosco, Daniela ^b   Ciampalini, Paolo ^b   Pantaleo, Antonio ^b   Vingolo, Enzo M ^a   Gargiulo, Patrizia ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b II Faculty of Medicine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; FIBRINOGEN; INSULIN; LUPUS ANTICOAGULANT; PROTHROMBIN; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HEMOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN C; PROTHROMBIN; RISK FACTORS;

EID: 0034100892     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.5.531     Document Type: Article

References (21)

1. Haefliger IO, Meyer P, Flammer J, et al. The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol 1994;39:123-32.
2. Kohner EM, Patel V, Rassman SMB. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 1995;44:603-7.
3. Andreani D. Malignant microangiopathy. Diabetologia 1980; 18:255.
4. Jones DB, Wallace R, Frier BM. Vascular endothelial cell antibodies in diabetic patients. Association with diabetic retinopathy. Diabetes Care 1992;15:552-5.
5. Lechner K, Pabinger Fasching I. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1985;15:254-62.
6. Triplett DA. Obstetrical complications associated with antiphospholipid antibodies. In: Coulama BC, Faulk WP, McIntyre JA, eds. Immunological obstetrics. New York: WW Norton, 1992:377-403.
7. Montehermoso A, Cervera R, Font J, et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Sem Arthritis Rheum 1999; 28:326-32.
8. Galtier-Dereure F, Biron C, Vies M, et al. Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies? Lupus 1998;7:469-74.
9. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol 1997;123:848-50.
10. National Diabetes Data Group. Classification of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
11. Diabetic Retinopathy Study Research Group. Report 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981;21:210-26.
12. Sharma SC. Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus. J Clin Pathol 1981;34:501-3.
13. Colmann RW, Hirsh J, Marder VJ, et al. Retinal microangiopathy, hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: Lippincott, 1987.
14. Walmsley D, Hampton KK, Grant PF. Contrasting fibrinolytic responses in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes. Diabetic Med 1991;8: 954-9.
15. Pandolfi M, Almèr LO, Holmberg L. Increased von Willebrand-antihaemophilic factor A in diabetic retinopathy. Acta Ophthalmol Scand 1974;52:823-8.
16. Brenner BM, Troy JL, Ballermann BJ. Endothelium-dependent vascular responses: mediator and mechanism. J Clin Invest 1989;84:1373-8.
17. Fuller JH, Keen H, Jarret RJ. Haemostatic variables associated with diabetes and its complications. Br Med J 1979;2: 964-6.
18. Garcia Frade LJ, De la Calle H, Torado MC, et al. Hypofibrinolysis associated with vasculopathy in non-insulin-dependent diabetes mellitus. Thromb Res 1990;59:51-9.
19. Mansfield MW, Grant PJ. Fibrinolysis and diabetic retinopathy in NIDDM. Diabetes Care 1995;18:1577-81.
20. Ceriello A, Giacomello R, Colatutto A, et al. Increased prothrombin fragment 1+2 in Type 1 diabetic patients. Haemostasis 1992;22:50-1.
21. Iwashima Y, Sato T, Watanabe K, et al Elevation of plasma thrombomodulin level in diabetic patients with early nephropathy. Diabetes 1990;39:983-8.